DaVita Labs appoints vp and general manager

Chronic kidney disease laboratory hires Leslie Mirani

DaVita Labs, a specialist laboratory focused on chronic kidney disease, has appointed Leslie Mirani as vice president and general manager.

Mirani brings to DaVita Labs more than 25 years’ experience in commercial sales and marketing – primarily renal-focused – in the pharmaceutical industry. She previously worked for Human Genome Sciences as an immunology sales director and as vice president for Amgen’s nephrology business unit for 18 years.

DaVita Labs has 86,700ft2 dedicated to its clinical diagnostic laboratories between its two locations in Fort Lauderdale and DeLand, Florida, US.

You may also like

Manufacturing
Adelphi launches next-generation XYZ Distributor II

Adelphi launches next-generation XYZ Distributor II

Integrated filling and dispensing platform delivers precise, contamination-controlled liquid handling
Manufacturing
ACI expands HPLC portfolio with premium check valves for liquid chromatography systems

ACI expands HPLC portfolio with premium check valves for liquid chromatography systems

New aftermarket check valves provide a cost-effective, high-reliability alternative for Agilent and Waters HPLC/UPLC systems
Cell & Gene Therapy
Syntax Bio and Applied StemCell partner to advance programmable iPSC therapy development

Syntax Bio and Applied StemCell partner to advance programmable iPSC therapy development

The collaboration combines ASC's hypoimmune iPSC lines with Syntax Bio's Cellgorithm platform, aiming to accelerate scalable allogeneic cell therapy development by addressing immune recognition and manufacturing variability
Pharmaceutical
MSD partners with Abu Dhabi to explore regional pharma logistics hub in HELM Cluster

MSD partners with Abu Dhabi to explore regional pharma logistics hub in HELM Cluster

The collaboration would strengthen supply chain resilience and accelerate access to innovative therapies across the region, subject to approvals, positioning Abu Dhabi as a secure distribution gateway for global pharma
Research & Development
Lonza and InduPro reveal licensing agreement to advance next-generation ADC therapeutics

Lonza and InduPro reveal licensing agreement to advance next-generation ADC therapeutics

The agreement enables InduPro to leverage Lonza platforms to develop targeted oncology therapies
Regulatory
Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

EU Pharma Legislation overhaul + Global GMP updates (2026)
Pharma 5.0
NVIDIA launches BioNeMo Agent Toolkit; Tecan adopts for Lab AI

NVIDIA launches BioNeMo Agent Toolkit; Tecan adopts for Lab AI

NVIDIA's BioNeMo Agent Toolkit provides AI agents with pharma-grade scientific tools, backed by Anthropic, OpenAI and 50+ partners. Tecan's announcement makes it among the first to integrate the toolkit into its Introspect lab platform
Subscribe now